Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies
Background: Chronic hepatitis C virus (HCV) infection is considered as one of the leading causes of liver disease in thalassemic patients in Iran. Over 40% of the mortality in these patients is related to HCV. Objectives: The present study aimed at estimating HCV prevalence in thalassemic patients i...
Main Authors: | Meisam Moghimbeygi, Seyed Moayed Alavian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Journal of Virus Eradication |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2055664020314552 |
Similar Items
-
The prevalence of Hepatitis C virus antibodies among thalassemia patients referring to Shahid Beheshti Hospital, Abadan, Iran
by: Sara Kooti, et al.
Published: (2017-11-01) -
The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis
by: Sohail Akhtar, et al.
Published: (2020-04-01) -
Detection of Hepatitis C Virus RNA in blood and saliva of transfusion-dependent thalassemia patients diagnosed with Hepatitis C
by: Behzad Hooshmand, et al.
Published: (2018-01-01) -
Prevalence of hepatitis E virus in thalassemia patients with hepatitis C in Tehran, Iran
by: Najmeh Dalvand, et al.
Published: (2020-01-01) -
Distribution of Hepatitis C Virus Genotypes in Patients with Major β-Thalassemia in Mashhad, Northeast Iran
by: Sanaz Ahmadi-Ghezeldasht, et al.
Published: (2018-01-01)